Application Nr Approved Date Route Status External Links
NDA209184 None Respiratory (Inhalation) None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Inbrija Is Indicated For The Intermittent Treatment Of Off Episodes In Patients With Parkinson's Disease Treated With Carbidopa/levodopa. Inbrija Is An Aromatic Amino Acid Indicated For The Intermittent Treatment Of Off Episodes In Patients With Parkinson's Disease Treated With Carbidopa/levodopa ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Levodopa LEVODOPA ZINC895199

Comments